SUMOylation of TBL1 and TBLR1 promotes androgen-independent prostate cancer cell growth
Open Access
- 26 April 2016
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (27) , 41110-41122
Abstract
SUMOylation of TBL1 and TBLR1 promotes androgen-independent prostate cancer cell growthKeywords
This publication has 28 references indexed in Scilit:
- Reversible SUMOylation of TBL1-TBLR1 Regulates β-Catenin-Mediated Wnt SignalingMolecular Cell, 2011
- Transducin β-Like Protein 1 Recruits Nuclear Factor κB to the Target Gene Promoter for Transcriptional ActivationMolecular and Cellular Biology, 2011
- Chronic inflammation, mutation and human diseaseMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2010
- Clinical and Correlative Results of SWOG S0354: A Phase II Trial of CNTO328 (Siltuximab), a Monoclonal Antibody against Interleukin-6, in Chemotherapy-Pretreated Patients with Castration-Resistant Prostate CancerClinical Cancer Research, 2010
- Direct Ubiquitination of β-Catenin by Siah-1 and Regulation by the Exchange Factor TBL1Journal of Biological Chemistry, 2010
- New Insights Into the Role of Interleukin-6 in Human Prostate CancerJournal of Urology, 2009
- Inflammation in Human Disease: Anticytokine TherapyTransplantation and Cellular Therapy, 2009
- Inflammation, infection, and prostate cancerCurrent Opinion in Urology, 2008
- TBL1 and TBLR1 Phosphorylation on Regulated Gene Promoters Overcomes Dual CtBP and NCoR/SMRT Transcriptional Repression CheckpointsMolecular Cell, 2008
- Reading and Function of a Histone Code Involved in Targeting Corepressor Complexes for RepressionMolecular and Cellular Biology, 2005